Cargando…

Distribution of high-risk human papillomavirus genotype prevalence and attribution to cervical precancerous lesions in rural North China

OBJECTIVE: Precise prevention is more desired for cervical cancer due to the huge population, high prevalence of human papillomavirus (HPV) infection in China and the vision of screen-and-treat strategies in low- and middle-income countries (LMICs). Considerations of combining type-specific prevalen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Shuang, Zhao, Xuelian, Hu, Shangying, Lu, Jessica, Duan, Xianzhi, Zhang, Xun, Chen, Feng, Zhao, Fanghui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6736663/ https://www.ncbi.nlm.nih.gov/pubmed/31564809 http://dx.doi.org/10.21147/j.issn.1000-9604.2019.04.10

Ejemplares similares

High-risk human papillomavirus genotype distribution and attribution to cervical cancer and precancerous lesions in a rural Chinese population
por: Zhao, Xue-Lian, et al.
Publicado: (2017)

Human papillomavirus genotypes associated with cervical precancerous lesions and cancer in the highest area of cervical cancer mortality, Longnan, China
por: Zhao, Jin, et al.
Publicado: (2017)

Absolute Risk and Attributable Fraction of Type-Specific Human Papillomavirus in Cervical Cancer and Precancerous Lesions—A Population-Based Study of 6286 Women in Rural Areas of China
por: Li, Li, et al.
Publicado: (2022)

Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in the Republic of Korea, 2014–2016
por: Ouh, Yung-Taek, et al.
Publicado: (2018)

Distribution of human papillomavirus genotypes in cervical lesions
por: Ma, Li, et al.
Publicado: (2017)

Distribution of human papillomavirus in precancerous and cancerous cervical neoplasia in Tunisian women
por: Bel Haj Rhouma, Rahima, et al.
Publicado: (2021)

miRNAs signature as potential biomarkers for cervical precancerous lesions in human papillomavirus positive women
por: González-Ramírez, Martha I., et al.
Publicado: (2023)

Cancer burden attributable to human papillomavirus infection by sex, cancer site, age, and geographical area in China
por: Duan, Rufei, et al.
Publicado: (2019)

Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in Beijing, China: analysis of results from China’s top 3 hospital, 2009–2019
por: Liu, Yidi, et al.
Publicado: (2020)

Human papillomavirus infections among women with cervical lesions and cervical cancer in Eastern China: genotype-specific prevalence and attribution
por: Zhang, Lei, et al.
Publicado: (2017)

Prevalence characteristics of high-risk human papillomaviruses in women living in Shanghai with cervical precancerous lesions and cancer
por: Gu, Ying, et al.
Publicado: (2016)

Risk Factors Associated With Human Papillomavirus Infection, Cervical Cancer, and Precancerous Lesions in Large-Scale Population Screening
por: Yang, Di, et al.
Publicado: (2022)

Vaccinating women previously treated for human papillomavirus-related cervical precancerous lesions is highly cost-effective in China
por: Zou, Maosheng, et al.
Publicado: (2023)

Raman spectroscopic study of cervical precancerous lesions and cervical cancer
por: Wang, Jing, et al.
Publicado: (2021)

Analysis of HPV distribution in patients with cervical precancerous lesions in Western China
por: Li, Kemin, et al.
Publicado: (2017)

Ki-67 and P16 proteins in cervical cancer and precancerous lesions of young women and the diagnostic value for cervical cancer and precancerous lesions
por: Shi, Qin, et al.
Publicado: (2019)

Health and economic impact of delaying large-scale HPV vaccination and screening implementation on cervical cancer in China: a modelling study
por: Gao, Meng, et al.
Publicado: (2023)

Human papillomavirus detection in cervical neoplasia attributed to 12 high-risk human papillomavirus genotypes by region()
por: Castellsagué, Xavier, et al.
Publicado: (2016)

An Improved Image Classification Method for Cervical Precancerous Lesions Based on ShuffleNet
por: Fang, Shan, et al.
Publicado: (2022)

Immunologic treatments for precancerous lesions and uterine cervical cancer
por: Vici, Patrizia, et al.
Publicado: (2014)

Distribution of Human Papillomavirus Genotypes in Iranian Women According to the Severity of the Cervical Lesion
por: Salehi-Vaziri, Mostafa, et al.
Publicado: (2016)

Genotype distribution of cervical human papillomavirus DNA in women with cervical lesions in Bioko, Equatorial Guinea
por: García-Espinosa, Benjamín, et al.
Publicado: (2009)

Development of biomarker panel to predict, prevent and create treatments tailored to the persons with human papillomavirus-induced cervical precancerous lesions
por: Lazarenko, Liudmyla M, et al.
Publicado: (2014)

Impact of HPV-16/18 AS04-adjuvanted vaccine on preventing subsequent infection and disease after excision treatment: post-hoc analysis from a randomized controlled trial
por: Zhao, Shuang, et al.
Publicado: (2020)

Human papillomavirus genotype-specific risks for cervical intraepithelial lesions
por: Nygård, Mari, et al.
Publicado: (2020)

Distribution of human papilloma virus genotype prevalence in invasive cervical carcinomas and precancerous lesions in the Yangtze River Delta area, China
por: WANG, Hongyun, et al.
Publicado: (2018)

Prevalence and Genotype Distribution of Human Papillomavirus in Invasive Cervical Cancer, Cervical Intraepithelial Neoplasia, and Asymptomatic Women in Southeast China
por: Wang, Xuelian, et al.
Publicado: (2018)

Effect of electronic health (eHealth) on quality of life in women with breast cancer: A systematic review and meta‐analysis of randomized controlled trials
por: Wen, Tianmeng, et al.
Publicado: (2023)

Clinical significance of HPV-DNA testing for precancerous cervical lesionS
por: Moarcăs, M, et al.
Publicado: (2014)

Relationship between the Cervical Microbiome, HIV Status, and Precancerous Lesions
por: Klein, Cameron, et al.
Publicado: (2019)

Colposcopy accuracy in diagnosing cervical precancerous lesions in western Kazakhstan
por: Balmagambetova, Saule, et al.
Publicado: (2020)

Precancerous cervical lesion in Ethiopia: systematic review and meta-analysis
por: Kasa, Ayele Semachew, et al.
Publicado: (2021)

The Accuracy of Cytology, Colposcopy and Pathology in Evaluating Precancerous Cervical Lesions
por: Pleş, Liana, et al.
Publicado: (2022)

GENOTYPING OF HUMAN PAPPILOMAVIRUS IN CERVICAL PRECANCEROUS LESION AND SQUAMOUS CELL CARCINOMA AT DR. SOETOMO HOSPITAL, SURABAYA, INDONESIA
por: Mastutik, Gondo, et al.
Publicado: (2018)

Effectiveness and cost-effectiveness of eliminating cervical cancer through a tailored optimal pathway: a modeling study
por: Xia, Changfa, et al.
Publicado: (2021)

Microendoscopy in vivo for the pathological diagnosis of cervical precancerous lesions and early cervical cancer
por: Liu, Min, et al.
Publicado: (2023)

Value of multi-quadrants biopsy: Pooled analysis of 11 population-based cervical cancer screening studies
por: Zhao, Yuqian, et al.
Publicado: (2020)

Incidence of cervical precancerous lesions and cervical cancer in Denmark from 2000 to 2019: Population impact of multi‐cohort vaccination against human papillomavirus infection
por: Ring, Linea Landgrebe, et al.
Publicado: (2022)

Progression of precancerous lesions of esophageal squamous cell carcinomas in a high‐risk, rural Chinese population
por: Gao, Dongqing, et al.
Publicado: (2022)

New serum biomarker identification and analysis by mass spectrometry in cervical precancerous lesion and acute cervicitis in South China
por: Qiu, Feng, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_j17rg1eeetntbjhuammjg69pmd